In the all cash deal, Sun Pharma will acquire the shares at a price of US $38 per ordinary share, which will be payable in full at the close of the proposed transaction, the company said in a BSE filing on Saturday. At present, Sun holds 78.48% stake in Taro.
May 28, 2023 at 04:11AM
0 Comments